<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bosticardo M</submitter><funding>Michael Smith Foundation for Health Research Health Professional-Investigator Award</funding><funding>DIR, NIAID, NIH</funding><funding>NIDDK NIH HHS</funding><funding>Center for Clinical and Translational Research at Brown University</funding><funding>Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children’s Hospital</funding><funding>Center for Cancer Research, National Cancer Institute, National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>549-561</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6731368</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>105(3)</volume><pubmed_abstract>FOXN1 is the master regulatory gene of thymic epithelium development. FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy, accounting for the nude/severe combined immunodeficiency (nu/SCID) phenotype in humans and mice. We identified several newborns with low levels of T cell receptor excision circles (TRECs) and T cell lymphopenia at birth, who carried heterozygous loss-of-function FOXN1 variants. Longitudinal analysis showed persistent T cell lymphopenia during infancy, often associated with nail dystrophy. Adult individuals with heterozygous FOXN1 variants had in most cases normal CD4&lt;sup>+&lt;/sup> but lower than normal CD8&lt;sup>+&lt;/sup> cell counts. We hypothesized a FOXN1 gene dosage effect on the function of thymic epithelial cells (TECs) and thymopoiesis and postulate</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.</pubmed_title><pmcid>PMC6731368</pmcid><funding_grant_id>U54 GM115677</funding_grant_id><funding_grant_id>GM115677</funding_grant_id><funding_grant_id>K08 DK116668</funding_grant_id><pubmed_authors>Niebur H</pubmed_authors><pubmed_authors>Prencipe R</pubmed_authors><pubmed_authors>Bhandoola A</pubmed_authors><pubmed_authors>Sharapova S</pubmed_authors><pubmed_authors>Bosticardo M</pubmed_authors><pubmed_authors>Giardino G</pubmed_authors><pubmed_authors>Tam JS</pubmed_authors><pubmed_authors>Gelfand EW</pubmed_authors><pubmed_authors>Biggs C</pubmed_authors><pubmed_authors>Kleiner GI</pubmed_authors><pubmed_authors>Hill DA</pubmed_authors><pubmed_authors>Seroogy CM</pubmed_authors><pubmed_authors>Hartog N</pubmed_authors><pubmed_authors>Sakovich I</pubmed_authors><pubmed_authors>Pignata C</pubmed_authors><pubmed_authors>Perez E</pubmed_authors><pubmed_authors>Ruffner M</pubmed_authors><pubmed_authors>Gebbia J</pubmed_authors><pubmed_authors>Cooper MA</pubmed_authors><pubmed_authors>Hayward A</pubmed_authors><pubmed_authors>Yemialyanava I</pubmed_authors><pubmed_authors>Padem N</pubmed_authors><pubmed_authors>Butte MJ</pubmed_authors><pubmed_authors>Cowan J</pubmed_authors><pubmed_authors>Abbott JK</pubmed_authors><pubmed_authors>Chen K</pubmed_authors><pubmed_authors>Heimall J</pubmed_authors><pubmed_authors>Peake J</pubmed_authors><pubmed_authors>Scalia G</pubmed_authors><pubmed_authors>Corsino C</pubmed_authors><pubmed_authors>Notarangelo LD</pubmed_authors><pubmed_authors>Yamazaki Y</pubmed_authors><pubmed_authors>Seeborg F</pubmed_authors><pubmed_authors>Elder ME</pubmed_authors><pubmed_authors>Sleasman JW</pubmed_authors><pubmed_authors>Crestani E</pubmed_authors><pubmed_authors>Bartnikas LM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.</name><description>FOXN1 is the master regulatory gene of thymic epithelium development. FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy, accounting for the nude/severe combined immunodeficiency (nu/SCID) phenotype in humans and mice. We identified several newborns with low levels of T cell receptor excision circles (TRECs) and T cell lymphopenia at birth, who carried heterozygous loss-of-function FOXN1 variants. Longitudinal analysis showed persistent T cell lymphopenia during infancy, often associated with nail dystrophy. Adult individuals with heterozygous FOXN1 variants had in most cases normal CD4&lt;sup>+&lt;/sup> but lower than normal CD8&lt;sup>+&lt;/sup> cell counts. We hypothesized a FOXN1 gene dosage effect on the function of thymic epithelial cells (TECs) and thymopoiesis and postulate</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2026-05-04T18:37:18.046Z</modification><creation>2020-10-29T08:33:05Z</creation></dates><accession>S-EPMC6731368</accession><cross_references><pubmed>31447097</pubmed><doi>10.1016/j.ajhg.2019.07.014</doi></cross_references></HashMap>